Nortech Labs Cialis Daily 5mg (Tadalafil) � 30 Tablets

Scientific Background

Tadalafil, widely known under the trade name Cialis, is a phosphodiesterase type 5 (PDE5) inhibitor that has been a subject of extensive clinical and pharmacological research since the early 2000s. Unlike its counterparts with shorter half-lives, Tadalafil is distinguished by its prolonged duration of action, which makes it suitable for once-daily dosing in specific therapeutic contexts. Its dual relevance in cardiovascular and urological research has secured its place as an important compound in modern pharmacology.

Pharmacological Properties

Tadalafil works by inhibiting the PDE5 enzyme, leading to increased levels of cyclic guanosine monophosphate (cGMP). This cascade enhances vasodilation and blood flow in target tissues. Research has also shown its impact on pulmonary vasculature, contributing to its application in pulmonary arterial hypertension studies. With a half-life of approximately 17.5 hours, Tadalafil provides sustained pharmacological activity, distinguishing it from shorter-acting PDE5 inhibitors.

Research Relevance

Originally investigated for erectile dysfunction, Tadalafil has since been examined in research on benign prostatic hyperplasia (BPH), pulmonary hypertension, and vascular endothelial function. Its role in modulating smooth muscle relaxation and improving hemodynamic parameters continues to be of interest in both clinical and experimental research. Studies have also explored its effects on quality-of-life measures and its potential in long-term daily use protocols.

Nortech Labs Quality Emphasis

Nortech Labs supplies Tadalafil in a 5mg oral tablet format, packaged in 30-count sets designed for once-daily dosing regimens. Each batch undergoes rigorous quality control procedures to ensure pharmaceutical-grade purity, uniformity, and accurate dosing. This standardized approach supports consistent outcomes and reproducibility in laboratory and educational research settings.

Key Considerations

• Compound type: Phosphodiesterase type 5 (PDE5) inhibitor

• Primary research interest: Vascular function, erectile physiology, pulmonary hypertension, urological health

• Dosage form: 5mg oral tablets, supplied in packs of 30

• Intended use: Research and educational purposes only